A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck

Clinical trial NCT01075841 · WITHDRAWN

Trial details

NCT number: NCT01075841
Sponsor: Merck KGaA, Darmstadt, Germany
Status: WITHDRAWN
Study type: OBSERVATIONAL

Neoplasms, Squamous Cell

Start date: 2009-03-01
Primary completion: 2009-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.